Maravai Lifescie
Price
Prix
GRAPH PAR
Questions fréquentes
Quelle est la capitalisation boursière de Maravai Lifescie ?
Quel est le bénéfice par action (BPA) de Maravai Lifescie ?
Quelles sont les évaluations des analystes et le prix cible de l'action Maravai Lifescie ?
Quel est le chiffre d'affaires de Maravai Lifescie sur les douze derniers mois ?
Quel est l'EBITDA de Maravai Lifescie ?
Quel est le flux de trésorerie disponible de Maravai Lifescie ?
Combien d'employés compte Maravai Lifescie, et à quel secteur d'activité appartient-elle ?
Quel est le flottant des actions de Maravai Lifescie ?
Finances
- Capitalisation boursière
- 761,70 M $US
- BPA (TTM)
- -1,649 $US
- Free Float
- 117,45 M
- Recettes (TTM)
- 276,92 M $US
- EBITDA (TTM)
- 14,17 M $US
- Cash-flow disponible (TTM)
- -10,71 M $US
Cotation
- 1D span
- 5,326 $US5,613 $US
- 52W span
- 4,275 $US11,56 $US
Notes des analystes
L'objectif de prix est de 8,977 $US et l'action est analysée par 15 analystes.
Acheter
8
Hold
6
Vendre
1
Informations
Maravai Lifesciences Holdings, Inc. is a life sciences company. It is engaged in providing products to enable the development of drug therapies, diagnostics, and novel vaccines and to support research on human diseases. The firm operates through the following segments: Nucleic Acid Production and Biologics Safety Testing. The Nucleic Acid Production segment focuses on the manufacturing and sale of highly modified nucleic acids products to support the needs of customers’ research, therapeutic and vaccine programs. The Biologics Safety Testing segment focuses on manufacturing and selling biologics safety and impurity tests and assay development services that are utilized by its customers in their biologic drug manufacturing activities. The company was founded by Eric Tardif and Carl W. Hull in March 2014 and is headquartered in San Diego, CA.
- Salariés
- 650
- Industries
- Biotechnology
- Secteur
- Soins de santé
Identifiant
- ISIN
- US56600D1072
- Ticker primaire
- MRVI